Publications by authors named "Eric Gillent"

Claim this Profile
D
Drug clearance by aldehyde oxidase: can we avoid clinical failure?
Francesca Toselli, Melanie Golding, Johan Nicolaï, Eric Gillent, Hugues Chanteux

Xenobiotica· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Setup of human liver-chips integrating 3D models, microwells and a standardized microfluidic platform as proof-of-concept study to support drug evaluation.
Benoit Cox, Patrick Barton, Reiner Class, Hannah Coxhead, Claude Delatour, Eric Gillent

Biomater Biosyst· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring of a progressive functional dopaminergic deficit in the A53T-AAV synuclein rats by combining 6-[F]fluoro-L-m-tyrosine imaging and motor performances analysis.
Guillaume Becker, Anne Michel, Mohamed Ali Bahri, Georges Mairet-Coello, Christian Lemaire, Eric Gillent

Neurobiol Aging· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a physiologically based pharmacokinetic-pharmacodynamic model for initial dose prediction and escalation during a paediatric clinical trial.
Trevor N Johnson, Khaled Abduljalil, Jean-Marie Nicolas, Pierandrea Muglia, Hugues Chanteux, Eric Gillent

Br J Clin Pharmacol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(-)--3-Benzylphenobarbital Is Superior to Omeprazole and (+)--3-Benzylnirvanol as a CYP2C19 Inhibitor in Suspended Human Hepatocytes.
Marie-Lynn Cuypers, Hugues Chanteux, Eric Gillent, Pierre Bonnaillie, Kenneth Saunders

Drug Metab Dispos· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of Azamulin to Determine the Contribution of CYP3A4/5 to Drug Metabolic Clearance Using Human Hepatocytes.
Hugues Chanteux, Maria Rosa, Claude Delatour, Johan Nicolaï, Eric Gillent

Drug Metab Dispos· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of In Vitro Passive Permeability in a P-gp-transfected LLC-PK1 Model on the Prediction of the Rat and Human Unbound Brain-to-Plasma Concentration Ratio.
Johan Nicolaï, Hélène Chapy, Eric Gillent, Kenneth Saunders, Anna-Lena Ungell

Pharm Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of P-glycoprotein in the brain disposition of seletalisib: Evaluation of the potential for drug-drug interactions.
Jean-Marie Nicolas, Hugues Chanteux, Johan Nicolaï, Frédéric Brouta, Delphine Viot, Eric Gillent

Eur J Pharm Sci· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis